Patent details

EP2968588 Title: ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS

Basic Information

Publication number:
EP2968588
PCT Application Number:
US2014027868
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147224505
PCT Publication Number:
WO2014143765
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-EGFR ANTIBODY DRUG CONJUGATE FORMULATIONS
French Title of Invention:
FORMULATIONS DE CONJUGUÉ ANTICORPS ANTI-EGFR-MÉDICAMENT
German Title of Invention:
ANTI-EGFR-ANTIKÖRPER-WIRKSTOFF-KONJUGAT-FORMULIERUNGEN
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
09/01/2019
EP Publication Date:
20/01/2016
PCT Publication Date:
18/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/01/2019
EP B1 Publication Date:
09/01/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/03/2024
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/01/2019
 
 

Name:
AbbVie Inc.
Address:
1 North Waukegan Road, North Chicago, IL 60064, United States (US)

Name:
Abbvie Deutschland GmbH & Co. KG
Address:
Max-Planck-Ring 2a, 65205 Wiesbaden, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
10/04/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KUMAR, Vineet
Address:
United States (US)

2

Name:
TSCHOEPE, Markus
Address:
Germany (DE)

3

Name:
KALETA, Katharina
Address:
Germany (DE)

Priority

Priority Number:
201361790490 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/19; A61P 35/00; A61K 47/68;

Publication

European Patent Bulletin

1

Issue number:
201902
Publication date:
09/01/2019
Description:
Grant (B1)

2

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed

3

Issue number:
201903
Publication date:
16/01/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
15/02/2023
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
18/04/2019 Outgoing Correspondence 1
10/04/2019 Power Of Attorney 1